BIOPHARMA PARTNER PROGRAM

Build the delivery strategy around the gene

We work on programs where payload size, tissue targeting or repeat administration is the limiting factor. Engagements run from early feasibility questions through joint preclinical development.

WHO WE WORK WITH

Three kinds of collaboration

Biopharma companies

Programs with a defined genetic payload and an unresolved delivery route.

Research institutions

Groups working on structural design, trafficking or expression questions.

Rare-disease organizations

Foundations and advocacy groups pursuing delivery for a specific genetic condition.

DELIVERY CHALLENGES

What the platform is intended to address

Payload above practical vector capacity. Full-length or multi-element constructs that currently have to be truncated or split.

Tissue-directed delivery. Programs where biodistribution rather than the transgene is the limiting factor.

Repeat administration. Indications where a single dose is unlikely to be sufficient, under preclinical evaluation.

Manufacturing route. Reproducible self-assembly considered as part of program planning.

COLLABORATION STRUCTURES

Shapes a program can take

Structure and terms are defined per program. No standard terms are published.

Research collaboration

A joint research program evaluating the Genobot architecture for a specific delivery challenge or indication.

Co-development

A co-developed program with shared design, evaluation and defined decision points.

Licensing discussion

Arrangements for specific indications or applications. Structure and terms subject to negotiation.

HOW TO ENGAGE

A straightforward three-step process

STEP 01

Reach out

Introduce your organization and describe the therapeutic or delivery challenge.

STEP 02

Scientific evaluation

A scientific exchange to assess fit and discuss possible collaboration structures.

STEP 03

Structure the partnership

Define scope, terms and milestones with our team.

Share only what you are comfortable disclosing. An initial inquiry does not create a confidential relationship. Please do not include confidential information until an agreement is in place.

Ready to explore a collaboration?

Contact our team to begin the conversation.